Jun 30, 2022
How Financial Toxicity Wreaks Havoc on Value-Based Payment Success, With Mark Fendrick, MD (Encore! EP308)
In this Encore, Stacey Richter revisits her conversation with Mark Fendrick, MD, director of the University of Michigan Center for Value-Based Insurance Design, about why patient benefit design and provider...
Jun 23, 2022
Buy and Bill vs. Pharmacy Bagging: Weighing the Options for Plan Sponsors, With Erik Davis and Autumn Yongchu (EP371)
Stacey Richter continues her conversation with Erik Davis and Autumn Yongchu of USI Insurance Services, comparing the real trade-offs among buy and bill, pharmacy bagging, site-of-care steering, and home...
Jun 16, 2022
How Hospitals Hide 6x Markups on Specialty Drug Bills, With Erik Davis and Autumn Yongchu. The Billing Tricks Behind 6x Markups on Infused Specialty Pharmacy Drugs. Episode 370.
Stacey Richter talks with Erik Davis and Autumn Yongchu of USI Insurance Services about how some health systems manage to charge up to six...
Jun 9, 2022
Brown Bagging, White Bagging, and Clear Bagging Explained, With Keith Hartman, RPh. A Field Guide to Specialty Pharmacy Bagging and Who Profits From Each Kind. Episode 369.
Stacey Richter talks with Keith Hartman, RPh, CEO of ContinuumRx, about the evolution of specialty pharmacy “bagging”—brown, white, clear, and...
Jun 2, 2022
Do You Know How Much Cancer Centers Get Paid to Put Patients on Drugs? With Aaron Mitchell, MD, MPH (Encore! EP282)
In this Encore rebroadcast, Stacey Richter revisits her conversation with Aaron Mitchell, MD, MPH, an oncologist and health services researcher at Memorial Sloan Kettering, about “buy and bill” — the...